DICE Therapeutics, Inc.
DICE · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $1,229,315 | $313,439 | $856,783 | $856,783 |
| - Cash | $461,393 | $115,826 | $59,687 | $8,468 |
| + Debt | $13,265 | $2,396 | $98 | $222 |
| Enterprise Value | $781,187 | $200,009 | $797,194 | $848,537 |
| Revenue | $0 | $1,125 | $863 | $5,775 |
| % Growth | -100% | 30.4% | -85.1% | – |
| Gross Profit | $0 | $1,125 | $863 | $5,775 |
| % Margin | – | 100% | 100% | 100% |
| EBITDA | -$83,008 | -$48,649 | -$22,885 | -$12,206 |
| % Margin | – | -4,324.4% | -2,651.8% | -211.4% |
| Net Income | -$81,664 | -$48,472 | -$23,752 | -$12,964 |
| % Margin | – | -4,308.6% | -2,752.3% | -224.5% |
| EPS Diluted | -2.07 | -3.91 | -1.02 | -0.56 |
| % Growth | 47.1% | -283.3% | -82.1% | – |
| Operating Cash Flow | -$64,322 | -$39,292 | -$20,679 | -$16,298 |
| Capital Expenditures | -$2,237 | -$718 | -$148 | -$981 |
| Free Cash Flow | -$66,559 | -$40,010 | -$20,827 | -$17,279 |